LUSEDRA

LOE Approaching

fospropofol disodium

NDAINTRAVENOUSSOLUTION
Approved
Dec 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
9

Clinical Trials (5)

NCT01195103Phase 4Terminated

Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery

Started Feb 2011
13 enrolled
Procedural SedationRegional Anesthesia BlockOrthopedic Surgery
NCT01308541Phase 1Completed

A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion

Started Jan 2011
20 enrolled
Monitored Anesthesia Care
NCT01260142Phase 4Completed

A PK/PD Study of Fospropofol Disodium Compared With Propofol Injectable Emulsion

Started Nov 2010
36 enrolled
Anesthesia
NCT01309984Phase 1Completed

A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure

Started Nov 2010
10 enrolled
Lactating Women
NCT01127438Phase 4Completed

A Dose-ranging Study to Evaluate the Safety and Efficacy of LUSEDRA (Fospropofol Disodium) as an Intravenous Sedative for Diagnostic or Therapeutic Colonoscopy in Adult Special Populations

Started Apr 2010
153 enrolled
Sedation